Elitek
(Rasburicase)ApprovedProtein / enzyme
Rasburicase is used to treat high uric acid levels in the blood that can occur in cancer patients, especially those with blood cancers being treated with chemotherapy. It helps prevent kidney damage and other complications from uric acid buildup.[2] Elitek is currently approved and in use across 5 indications[4].[1]
Elitek is one of 127 small molecule programs targeting Arthritis. It is currently in Approved.
5
Indications
21
Total Trials
1
Active Trials
126
Competitors
1
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Status by Indication[4][1]
Indication
Competition
Competitive Landscape
375 competitors in Lymphoma
#DrugCompanyPhaseTrials
1Elitek
AAzienda U.S.L. 1 di Massa e Carrara
Approved
Cabenuva
GSKPreclinical
Norvir
AbbViePreclinical
Emend
CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Preclinical
Kenalog
BBausch Health Americas, Inc.
Preclinical
Nuvigil
NNuvo Research GmbH
Preclinical
Decadron
QQuince Therapeutics S.p.A.
Preclinical
Solu-Medrol
MMassachusetts Eye and Ear Infirmary
Preclinical
Systemic Therapy
Bristol-Myers SquibbPreclinical
JY231
SShenzhen Genocury Biotech Co., Ltd.
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Tumor Lysis Syndrome6 trials
Hyperuricemia4 trials
Show 1 more trial
Leukemia2 trials
7 more indications
Arthritis1 trial
Rasburicase Treatment in Chronic Gouty Arthritis
Unknown status·SSun Yat-Sen Memorial Hospital of Sun Yat-Sen University·Phase 4·NCT05312268·60 enrolled
Graft Versus Host Disease1 trial
Acute Leukemia1 trial
Hematologic Malignancies1 trial
Regulatory
FDA Approval Timeline[5]
Jul 12, 2002
ELITEK
BLA BLA103946
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Elitek drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Rasburicase. EMBL-EBI & Wellcome Sanger Institute.
- [5]
- [6]
Details